Roberto Cattaneo

Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2002 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Adherens junction protein nectin-4 is the epithelial receptor for measles virus

Michael D. Mühlebach, Mathieu Mateo, Patrick L. Sinn et al. · Nature · 2011 · 589 citations

Life Sciences, Immunology, Molecular Biology +14

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, D. D’Cruz et al. · Annals of the Rheumatic Diseases · 2009 · 540 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Biased hypermutation and other genetic changes in defective measles viruses in human brain infections

Roberto Cattaneo, Anita Schmid, D. Eschle et al. · Cell · 1988 · 437 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2004 · 387 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14